BioBlast Pharma (ORPN) Reports Q3 Loss of $0.28/Share

November 29, 2016 8:03 AM EST
Get Alerts ORPN Hot Sheet
Trade ORPN Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

BioBlast Pharma (NASDAQ: ORPN) reported Q3 EPS of ($0.28), versus ($0.25) reported last year.

Cash, cash equivalents and short-term bank deposits as of September 30, 2016, were $12.9 million, compared to $15.7 million as of June 30, 2016, primarily reflecting the Company’s third quarter operating expenditures. The Company expects to have at the end of 2016 between $8 to $9 million in cash, cash equivalents and short-term bank deposits.

For earnings history and earnings-related data on BioBlast Pharma (ORPN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment